These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 23985622)

  • 1. Fosphenytoin y-site stability studies with Lorazepam and midazolam hydrochloride.
    Riggs RM; English BA; Webster AA; McGuire JM; Riordan JM; Worthington MA
    Int J Pharm Compd; 1999; 3(3):235-8. PubMed ID: 23985622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y-site stability of fosphenytoin and sodium phenobarbital.
    English BA; Riggs RM; Webster AA; Benner KW
    Int J Pharm Compd; 1999; 3(1):64-6. PubMed ID: 23985449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical stability of palonosetron hydrochloride with Lorazepam and midazolam hydrochloride during simulated y-site administration.
    Trissel LA; Xu QA
    Int J Pharm Compd; 2005; 9(3):235-7. PubMed ID: 23924982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
    Bhatt-Mehta V; Hirata S
    Int J Pharm Compd; 1998; 2(1):79-82. PubMed ID: 23989485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
    Thompson DF; Stiles ML; Allen LV; Tu YH
    Am J Hosp Pharm; 1988 Jan; 45(1):142-5. PubMed ID: 3348228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures.
    Riley CM; Junkin P
    Am J Hosp Pharm; 1991 Jun; 48(6):1245-52. PubMed ID: 1650135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated y-site administration.
    Inagaki K; Kambara M; Mizuno M; Okuda J; Gill MA; Nishida M
    Int J Pharm Compd; 1998; 2(4):318-21. PubMed ID: 23989642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    Am J Hosp Pharm; 1992 Nov; 49(11):2769-72. PubMed ID: 1471644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical compatibility of depacon(®) with medications frequently administered by intravenous y-site delivery in patients with epilepsy or head trauma.
    Rashed SM; Sweatman TW; Thoma L; Hovinga CA; Phelps SJ
    J Pediatr Pharmacol Ther; 2004 Apr; 9(2):126-32. PubMed ID: 23118699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of dobutamine hydrochloride in selected large-volume parenterals.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
    Campbell S; Nolan PE; Bliss M; Wood R; Mayersohn M
    Am J Hosp Pharm; 1986 Apr; 43(4):917-21. PubMed ID: 3706337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.
    Riley CM
    Am J Hosp Pharm; 1988 Oct; 45(10):2079-91. PubMed ID: 3228079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intropin (dopamine hydrochloride) intravenous admixture compatibility, Part 3: stability with miscellaneous additives.
    Gardella LA; Kesler H; Amann A; Carter JE
    Am J Hosp Pharm; 1978 May; 35(5):581-4. PubMed ID: 655182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
    Strom JG; Miller SW
    Am J Hosp Pharm; 1991 Jun; 48(6):1237-41. PubMed ID: 1858803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions.
    Yuen PH; Taddei CR; Wyka BE; Chaudry IA
    Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.